Insider Cluster (7 insiders) ·Filed Feb 26, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 3 insiders, $12.2M total
Actionable Insight • Neutral

No material insider selling beyond routine activity; the grants and exercises are standard compensation events. Traders should not interpret this cluster as a negative signal.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
TEVA ▲ +1.23% at T+60d
NEUTRAL call ✓ call won +1.23% · α vs SPY -6.52% · entry $33.75 → $34.16
Entry anchored
Feb 25, 04:54 PM ET
via exchange tick
T+1d
+0.24%
call +0.24% · α +0.69%
$33.83
settled 7mo ago
T+5d
-5.93%
call -5.93% · α -4.80%
$31.75
settled 7mo ago
T+20d
-11.82%
call -11.82% · α -5.42%
$29.76
settled 6mo ago
T+60d
+1.23%
call +1.23% · α -6.52%
$34.16
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Teva executives executed derivative exercises and received share grants totaling $0 in cash value, with only two open-market sales: EVP Shields sold $547.7K and Interim CLO Savage sold $35.7K. The cluster is dominated by non-cash, routine compensation activities, with minimal open-market selling.

Key Financial Metrics

Direction
selling
Total Value
$583.4K
Insiders
7

Key Facts

  • EVP Shields sold $547,705 in open-market shares, the largest cash transaction in the cluster.
  • Interim CLO Savage sold $35,690 in open-market shares.
  • All other transactions were non-cash: derivative exercises (M), grants (A), or awards with $0 value.
  • CEO Francis received a grant of 136,736 shares; CFO Kalif and other executives exercised derivatives but did not sell shares.
  • Total open-market selling: $583,395 — consistent with prior 30-day activity.

Financial Impact

$583,395 in total open-market sales over 7 days, representing 0.0016% of Teva's $35.7B market cap

insider ownershipshare count (dilution from grants)

Risk Factors

  • Perception risk if investors misinterpret derivative exercises or grants as active selling.
  • Future open-market sales by other executives could increase selling pressure.

Market Snapshot

Exchange
OTC

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (20 trades, 7d window)cluster-TEVA-1773086989654
31 reports for TEVA
Performance horizon
100% Hit rate 9 of 9 directional calls best @ T+20▲ +17.61%Jul 20, 2026
Filters
Rows
Reports for TEVA — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Press Release
NEUTRAL ★ 5/10
$36.35 $39.19▲ +7.81%▲ +8.31%$39.53 (+8.75%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 5/10
$36.76 $39.25▲ +6.77%▲ +7.89%$39.53 (+7.54%)
Sep 2, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$37.49 $36.35▼ −3.04%▼ −2.08%$39.53 (+5.44%)
Aug 28, 2026
5w ago
Press Release
BULLISH ★ 6/10
$36.44 $36.36▼ −0.22%▼ −0.33%$39.53 (+8.48%)
Aug 25, 2026
5w ago
Court Ruling
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.53 (+3.75%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.10 $36.20▼ −4.99%▼ −4.46%$39.53 (+3.75%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.14 $36.46▲ +0.89%▲ +0.93%$39.53 (+9.38%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.81 $36.45▲ +4.70%▲ +3.49%$39.53 (+13.56%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$35.01 $35.36▲ +1.00%▼ −2.51%$39.53 (+12.91%)
Jul 29, 2026
9w ago
8-K
MIXED ★ 5/10
$34.71 $34.72▲ +0.03%▼ −5.50%$39.53 (+13.89%)
Showing 10 of 31

US Market Status

Market Closed — Opens Mon (64h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 9, 2026